Companies / Nigeria
GSK Nigeria Records Promising Results
May 2007 | Industry NewsThe Nigerian unit of UK-based drugmaker GlaxoSmithKline (GSK) has defied difficult operating conditions to record impressive financial results for 2006 with turnover rising 21% to NGN10.4bn (US$81.8mn). The company also generated a profit before tax of NGN1.5bn (US$11.8mn), an increase of 8% y-o-y, despite continuing problems with poor infrastructure and an erratic power supply.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
